The Alpha Journal — Men’s Health Reporting

Research-grade retatrutide costs $250–400 per month from peptide suppliers as of mid-2026, with individual vials priced at $40–120 for 5 mg, $70–200 for 10 mg, and $150–400 for 20–30 mg depending on vendor and bulk-order status. That translates to roughly $0.80–$1.20 per milligra

Short-acting injectable testosterone (primarily testosterone cypionate and enanthate) is the most common TRT method in 2025, delivered via intramuscular or subcutaneous injection every 1-2 weeks. While topical gels remain popular, injectables have become the dominant modality in routine U.S. clinical practice due to their efficacy, cost-effectiveness, and patient preference.

Tirzepatide vs semaglutide — head-to-head comparison for men. Weight loss results, side effects, cost, and how to find a GLP-1 provider near you.

Yes, BPC-157 can be taken orally and research suggests it remains stable in gastric acid, making oral administration a viable alternative to injectable forms for many therapeutic applications, though bioavailability may differ between routes.

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to produce natural growth hormone, which then reduces visceral fat by enhancing lipolysis and fat metabolism, particularly in patients with HIV-associated lipodystrophy.

Ozempic (semaglutide) does not directly damage kidneys, but can cause acute kidney injury in rare cases, primarily through dehydration from gastrointestinal side effects. Clinical trials show potential long-term kidney protective benefits for diabetic patients, though monitoring is essential for those with pre-existing kidney conditions.

Yes, Ozempic (semaglutide) has been associated with an increased risk of acute pancreatitis, though the overall risk remains relatively low. Clinical studies and post-market surveillance have identified pancreatitis as a potential side effect, occurring in approximately 0.2-1% of patients taking GLP-1 receptor agonists.

Current research shows mixed evidence on whether semaglutide causes depression. While some studies suggest a potential link to mood changes in certain individuals, large-scale clinical trials have not established a definitive causal relationship between semaglutide and depression.

Yes, semaglutide can cause headaches as a documented side effect. Clinical trials show headaches occur in 5-14% of patients, typically during the initial weeks of treatment as the body adjusts to the medication.